ARTICLE | Clinical News
Torisel temsirolimus: Phase III data
May 21, 2012 7:00 AM UTC
Top-line data from the open-label, international Phase III INTORSECT (B1771003) trial in 512 patients with advanced RCC who failed first-line treatment with Sutent sunitinib showed that once-weekly 2...